Association of clinical and pathological variables with survival in thymoma

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 2221-2228

  Aydiner, Adnan ^a   Toker, Alper ^b   Sen, Fatma ^a   Bicakci, Ercan ^a   Saglam, Esra Kaytan ^a   Erus, Suat ^b   Eralp, Yesim ^a   Tas, Faruk ^a   Oral, Ethem Nezih ^a   Topuz, Erkan ^a   Dilege, Sukru ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Masaoka; Myasthenia gravis; Survival; Thymoma; World Health Organization

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; COMORBIDITY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SCHOOL CHILD; THYMOMA; TURKEY (REPUBLIC); WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; THYMOMA; THYMUS NEOPLASMS; YOUNG ADULT;

EID: 84872768366     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0101-z     Document Type: Article

References (24)

1. Smit EF. Thymic malignancies. Ann Oncol. 2008;19:309-12.
2. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol. 2001;25:103-10.
3. Travis WD, Brambilla E, Müler-Hermelink HK, Harris CC. Pathology and genetics of tumors of the lung, pleura, thymus and heart. World Health Organization classification of tumors. Lyon: IARC Press; 2004.
4. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1, 320 patients from Japan. Ann Thorac Surg. 2003;76:878-84.
5. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485-92.
6. Fernandes AT, Shinohara ET, Guo M, Mitra N, Wilson LD, Rengan R, et al. The role of radiation therapy in malignant thymoma: a surveillance, epidemiology, and end results database analysis. J Thorac Oncol. 2010;5:1454-60.
7. Loehrer PJ Sr, Jiroutek M, Aisner S, Aisner J, Green M, Thomas CR Jr, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer. 2001;91:2010-5.
8. Loehrer PJ Sr, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol. 1994;12:1164-8.
9. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg. 1991;51:152-6.
10. Masaoka A. Staging system of thymoma. J Thorac Oncol. 2010; 5:304-12.
11. Fang W, Chen W, Chen G, Jiang Y. Surgical management of thymic epithelial tumours: a retrospective review of 204 cases. Ann Thorac Surg. 2005;80:2002-7.
12. Kim DJ, Yang WI, Choi SS, Kim KD, Chung KY. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumours: a clinicopathologic study of 108 patients and literature review. Chest. 2005; 127:755-61.
13. Howard FM Jr, Lennon VA, Finley J, Matsumoto J, Elveback LR. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci. 1987;505:526-38.
14. Nakagawa K, Asamura H, Matsuno Y, Suzuki K, Kondo H, Maeshima A, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg. 2003;126:1134-40.
15. Whooley BP, Urschel JD, Antkowiak JG, Takita H. A 25-year thymoma treatment review. J Exp Clin Cancer Res. 2000;19:3-5.
16. Chen G, Marx A, Wen-Hu C, Yong J, Puppe B, Stroebel P, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002;95:420-9.
17. Lee HS, Kim ST, Lee J, Choi YS, Han JH, Ahn YC, et al. A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management. Br J Cancer. 2007;97:22-8.
18. Ströbel P, Bauer A, Puppe B, Kraushaar T, Krein A, Toyka K, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol. 2004;15:1501-9.
19. Ruffini E, Mancuso M, Oliaro A, Casadio C, Cavallo A, Cianci R, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg. 1997;113:55-63.
20. Wu KL, Mao JF, Chen GY, Fu XL, Qian H, Jiang GL. Prognostic predictors and long-term outcome of postoperative irradiation in thymoma: a study of 241 patients. Cancer Invest. 2009;27: 1008-15.
21. Nakahara K, Ohno K, Hashimoto J, Maeda H, Miyoshi S, Sakurai M, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg. 1988;95:1041-7.
22. Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E, Harris NL. Thymoma: histologic subclassification is an independent prognostic factor. Cancer. 1994;74:606-17.
23. Rena O, Papalia E, Oliaro A, Ruffini E, Filosso P, Novero D, et al. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur J Cardiothorac. 2007;31:109-13.
24. Regnard JF, Magdeleinat P, Dromer C, Dulmet E, de Montpreville V, Levi JF, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg. 1996;112:376-84.